Researchers have identified striking genetic parallels between cancers in domestic cats and humans, potentially unlocking new treatment pathways for both species. The discovery marks a watershed moment in oncology, revealing that feline tumors share many of the same cancer-driving mutations found in human malignancies.
An international team analyzed tumor samples from nearly 500 cats across five countries in what represents the first large-scale genetic profiling of feline cancers. The study, published in Science, uncovered genetic similarities spanning multiple cancer types, including tumors affecting the blood, bones, lungs, skin, gastrointestinal tract, and central nervous system.
The most striking finding centered on mammary cancers in cats. Researchers discovered that the gene FBXW7 was mutated in more than half of feline mammary tumors studied. That same gene, when altered in human breast cancer patients, is associated with worse outcomes. The match between species proved unmistakable.
"Despite domestic cats being common pets, there was very little known about the genetics of cancer in these animals until now," said Dr. Geoffrey Wood, a University of Guelph pathobiology professor and study co-author. The lack of understanding had persisted even as cancer emerged as a leading cause of disease and death in cats.
The research team also identified a potential therapeutic breakthrough. Certain chemotherapy drugs appeared more effective in cat mammary tumors carrying the mutated FBXW7 gene, at least when tested on tissue samples. While these results remain preliminary, they suggest a roadmap for developing new breast cancer treatments applicable to both animals and humans.
"Having access to such a large set of donated tissues allowed us to assess drug responses across tumor types in a way that hasn't been possible at this scale before," said Dr. Sven Rottenberg, co-senior author at the University of Bern.
Scientists theorize that shared environmental exposures between cats and their owners may explain some of the genetic overlap in cancer development. Cats spend considerable time indoors alongside humans, potentially exposing them to similar carcinogens and other risk factors that shape cancer formation.
One Medicine Bridge Between Species
The project represents a collaborative framework called One Medicine, which systematically bridges veterinary and human medical research. Researchers from the Wellcome Sanger Institute, University of Guelph, University of Bern, and other institutions pooled resources to sequence DNA from tissue samples previously collected by veterinarians for diagnostic purposes.
This approach creates a virtuous cycle: treatments already used in humans could eventually be tested in cats, while information gained through feline cancer trials could guide future human clinical research. The strategy essentially treats human and animal health as interconnected rather than siloed domains.
Dr. Louise Van Der Weyden, a senior author at the Wellcome Sanger Institute, emphasized the significance of this framework. "We can now begin to take the next steps towards precision feline oncology, to catch up with the diagnostic and therapeutic options that are available for dogs with cancer, and ultimately one day, humans."
The research received backing from multiple organizations, including the EveryCat Health Foundation, CVS Group, Wellcome, the Natural Sciences and Engineering Research Council of Canada, and the Swiss National Science Foundation.
Author Jessica Williams: "This study transforms house cats from innocent bystanders into genuine medical research partners, and the implications for both veterinary medicine and human oncology could reshape how we approach cancer treatment within the decade."
Comments